SCHEMBL18838820

SCHEMBL18838820

COc1c(C)cc(O)c(-c2c(O)c(O)c(-c3c(O)cc(C)c(OC)c3C)c3ccccc23)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.44
LMNA P02545 1/20 0.44
PDE4B Q07343 5/20 0.43
PDE4A P27815 4/20 0.43
PDE4C Q08493 4/20 0.43
PDE4D Q08499 4/20 0.43
KDM4E B2RXH2 3/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PIM1 P11309 1/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
ERN1 O75460 1/20 0.38
EP300 Q09472 1/20 0.36
KCNB1 Q14721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18838215 0.87 KDM4E (0.43) HTTLMNAPDE4BPDE4APDE4C
SCHEMBL18838172 0.84 TUBB4A (0.42) HTTLMNAPDE4BPDE4APDE4C
SCHEMBL18838817 0.83 KDM4E (0.40) HTTLMNAPDE4BPDE4APDE4C
SCHEMBL18838238 0.82 MAPT (0.48) HTTKDM4ETP53GAAMAPT
SCHEMBL18838181 0.81 HTT (0.44) HTTLMNAPDE4BPDE4APDE4C
SCHEMBL18838239 0.80 PDE4B (0.40) HTTLMNAPDE4BPDE4APDE4C
SCHEMBL9812714 0.75 KDM4E (0.64) HTTLMNAPDE4BPDE4APDE4C
SCHEMBL18838816 0.75 ALOX5 (0.45) PDE4BPDE4APDE4CPDE4DGAA
SCHEMBL18871343 0.75 PKM (0.41) HTTLMNAPDE4BPDE4APDE4C
SCHEMBL18838191 0.75 PIM1 (0.45) PDE4BPDE4APDE4CPDE4DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190202774-A1 BIARYL COMPOUNDS AS ANTIMICROBIAL AND CHEMOTHERAPEUTIC AGENTS WILLIAM MARSH RICE UNIVERSITY (US) 2019-07-04 US disclosed
US-20190202774-A1 BIARYL COMPOUNDS AS ANTIMICROBIAL AND CHEMOTHERAPEUTIC AGENTS WILLIAM MARSH RICE UNIVERSITY (US) 2019-07-04 US disclosed
WO-2017083702-A1 BIARYL COMPOUNDS AS ANTIMICROBIAL AND CHEMOTHERAPEUTIC AGENTS WILLIAM MARSH RICE UNIVERSITY (US) 2017-05-18 WO disclosed
WO-2017083719-A1 TRANSITION METAL FREE METHODS OF SYNTHESIS OF BIARYL COMPOUNDS WILLIAM MARSH RICE UNIVERSITY (US) 2017-05-18 WO disclosed
WO-2017083702-A1 BIARYL COMPOUNDS AS ANTIMICROBIAL AND CHEMOTHERAPEUTIC AGENTS WILLIAM MARSH RICE UNIVERSITY (US) 2017-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190202774-A1 BIARYL COMPOUNDS AS ANTIMICROBIAL AND CHEMOTHERAPEUTIC AGENTS MCL1, BCL2, BCL2L2 HTT 4231/4885LMNA 3145/4885PDE4B 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.